-
DOPE: A Helper Lipid for Delivery and Ferroptosis
2026-08-30
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is a phosphatidylethanolamine helper lipid that supports acidic endosomal membrane fusion and nucleic acid release. A 2026 study also reported that exogenous DOPE partially restored developmental conidial-death defects in Magnaporthe oryzae mutants, but this fungal result does not by itself establish a delivery formulation or clinical application.
-
Tunicamycin for ER Stress and UPR Assays
2026-08-29
Tunicamycin is a mechanistically defined N-glycosylation inhibitor for building controlled ER-stress, macrophage inflammation, and proteostasis assays. This practical guide connects RAW264.7 workflows with new C. elegans evidence showing why calibrated, mild UPR activation can be more informative than maximal stress.
-
Tofacitinib Citrate: A Smarter Assay Framework
2026-08-28
Tofacitinib citrate is more than a JAK3 inhibitor: it is a context-dependent perturbation tool for immune regulation research. This guide integrates biochemical selectivity, lymphocyte assays, and endothelial inflammation data into a practical experimental framework.
-
Phenothiazines, ROS, and Macrophage Autophagy
2026-08-28
The reference study shows that phenothiazines strengthen macrophage control of intracellular bacteria through coordinated increases in lysosomal activity, reactive oxygen species, and autophagy. Its inhibitor and scavenger experiments support a host-directed antibacterial mechanism, while in vivo perphenazine data provide an initial translational bridge for infection and inflammation research.
-
AU-24118 and ABCB1-Mediated PROTAC Resistance
2026-08-28
The reference study introduces AU-24118, an orally bioavailable PROTAC degrader designed to eliminate mSWI/SNF ATPase components in castration-resistant prostate cancer. It also identifies SMARCA4 bromodomain mutations and ABCB1 overexpression as distinct acquired resistance mechanisms, showing that transporter-directed intervention can restore sensitivity to several PROTAC classes.
-
α2-AR Agonists in Osteosarcoma Recurrence
2026-08-27
The reference study evaluates local delivery of the α2-adrenergic receptor agonist UK14,304 in a thermo-sensitive hydrogel after osteosarcoma resection. Its findings support an immune-mediated reduction in recurrence, linked to CD8+ T-cell activity, T-cell receptor signaling, and ITGAL-centered regulation rather than direct tumor-cell toxicity.
-
HMGCS2, LysoPC, and Pulmonary Fibrosis
2026-08-26
Yang et al. identify injured type II alveolar epithelial cells as a major source of accumulated lysophosphatidylcholine during bleomycin-induced pulmonary fibrosis and show that released LysoPC can activate lung fibroblasts. Their experiments connect reduced epithelial HMGCS2 to impaired lipid degradation through a PPARα–CPT1A/CPT2 axis, suggesting a mechanistically defined target for further fibrosis research.
-
Ceramides Drive RGNNV Infection: Lipidomics Insights
2026-08-26
Zhang and colleagues combine global lipidomics with pathway perturbation, protein localization, gene knockdown, and metabolic rescue to show that ceramide accumulation supports red-spotted grouper nervous necrosis virus replication. The study identifies ceramide flux and autophagy as mechanistically connected, while also defining important limits for translating cell-based findings into aquaculture interventions.
-
WM-8014: Time-Resolved Epigenetic Assay Design
2026-08-26
WM-8014 is a reversible KAT6A inhibitor for dissecting chromatin-dependent growth arrest without equating reduced proliferation with cell death. This guide connects its mechanism and model evidence with RESTRICT-seq principles to improve time-resolved cancer biology research and assay interpretation.
-
How Kinase Inhibitors Accelerate p38α Dephosphorylation
2026-08-25
The reference preprint shows that selected kinase inhibitors can both inhibit p38α catalysis and accelerate WIP1-mediated removal of its activation-loop phosphothreonine. This dual-action mechanism links inhibitor binding to kinase conformational control and suggests a route toward more durable and selective inhibition of p38 MAPK signaling.
-
Ruxolitinib: From JAK Biology to Immune Translation
2026-08-24
Ruxolitinib (INCB018424) is more than a selective JAK1/2 kinase inhibitor: it is a mechanistic tool for connecting JAK-STAT signaling pathway inhibition with progenitor-cell biology and tumor immune remodeling. This article outlines experimental strategies for myelofibrosis research, oncogenic JAK2 fusion protein studies, and combination immunotherapy models while distinguishing biochemical potency from translational evidence.
-
Bufalin: A Mechanistic Roadmap for TNBC Research
2026-08-24
Bufalin is more than a cardiotonic steroid with broad anticancer activity: emerging evidence positions it as a mechanism-led research probe that can connect direct target engagement, protein degradation, apoptosis, and translational modeling in triple-negative breast cancer. This article examines how STK33 biology, assay design, formulation discipline, and model selection can turn a natural-product signal into a more rigorous development hypothesis.
-
Honokiol Workflows for Cancer Drug Response
2026-08-23
Honokiol can help researchers separate growth inhibition, cell killing, NF-κB signaling, and oxidative-stress effects in cancer and inflammation models. This practical workflow combines dose preparation, time-resolved viability measurements, death confirmation, and mechanism-focused controls to reduce misleading single-assay conclusions.
-
Phosphotungstic Acid Negative Stain Guide
2026-08-22
Phosphotungstic Acid Negative Stain Solution (2%) provides a practical route to high-contrast particle imaging while preserving scientific restraint. This guide connects negative-stain electron microscopy with coronavirus entry research and explains which assay decisions the method can—and cannot—support.
-
Wnt-C59: Practical PORCN Inhibition Workflows
2026-08-21
Wnt-C59 is a high-potency PORCN inhibitor for separating Wnt ligand secretion from downstream pathway activation in reporter, cancer, and exosome-related assays. This guide translates its mechanism into practical workflows, comparative experiments, and troubleshooting strategies while distinguishing established product evidence from proposed applications.